期刊文献+

瑞舒伐他汀对老年慢性心力衰竭患者心功能的影响 被引量:10

Effect of Rosuvastatin on Cardiac Function of Elderly Patients with Heart Failure
下载PDF
导出
摘要 目的:观察瑞舒伐他汀对老年慢性心力衰竭(CHF)患者心功能的影响。方法:将80例老年(>60岁)CHF患者随机分为对照组和研究组,每组40例。对照组给予常规抗心力衰竭治疗,研究组在此基础上加用瑞舒伐他汀,剂量为5mg,每晚1次口服。治疗前后,评价心功能改变,心脏多普勒超声检查和检测C-反应蛋白(CRP)水平。结果:6个月时,研究组心功能改善有效率与对照组相比差异有统计学意义(P<0.05);两组左室射血分数(LVEF)均升高,研究组较对照组升高明显(P<0.05);两组CRP水平均下降,研究组较对照组下降明显(P<0.05)。结论:瑞舒伐他汀可以改善老年CHF患者心功能和降低CRP水平。 Objective:To observe the effect of rosuvastatin on cardiac function of elderly patients with heart failure.Method:80 elderly patients(age60) with heart failure were randomly assigned to regular treatment group (40) and rosuvastatin treatment group(40).All of them were given either regular anti-heart failure treatment or rosuvastatin(5 mg qn) additionally.Cardiac function,echocardiography and concentration of CRP were detected before and after treatment.Result:After 6 months treatment,there was statistic difference in cardiac function improvement between two gruops(P0.05).Left ventricular ejection fraction(LVEF) rised more significantly in rosuvastatin treatment group than regular treatment group.The CRP level of both groups were descreased, the decline in rosuvastatin treatment group was more significant(P0.05).Conclusion:Rosuvastatin can improve cardiac function of elderly patients with heart failure and decrease the plasma CRP level.
出处 《中国医学创新》 CAS 2013年第1期19-20,共2页 Medical Innovation of China
关键词 瑞舒伐他汀 心力衰竭 心功能 Rosuvastatin Heart failure Cardiac function
  • 相关文献

参考文献4

二级参考文献39

  • 1张启华,刘亚娟.充血性心力衰竭患者血清CRP水平的变化及与心功能的关系[J].中外医疗,2008,27(17). 被引量:5
  • 2Igarashi J,Miyoshi M,Hashimoto T,et al.Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins[J].Br J Pharmacol,2007,150(4):470-479.
  • 3Landmesser U,Engberding N,Ferdinand H,et al.Statin-induced improvement of endothelial progenitor cell mobilization,myocardial neovascularization,left ventricular function,and survival after experimental myocardial infarction requires endothelial nitric oxide synthase[J].Circulation,2004,110(14):1933-1939.
  • 4Yamanouchi D,Banno H,Nakayama M,et al.Hydrophilic statins suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition[J].J Vasc Surg,2005,42 (4):757-764.
  • 5Ohkita M,Sugii M,Ka Y,et al.Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells[J].Exp Biol Med,2006,231(7):772-776.
  • 6Schafer A,Fraccarollo D,Eigenthaler M,et al.Rosuvastatin reduces platelet activation in heart failure:role of NO bioavailability[J].Arterioscler Thromb Vasc Biol,2005,25(5):1071-1077.
  • 7Nakata S,Tsutsui M,Shimokawa H,et al.Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway[J].Arterioscler Thromh Vasc Biol,2007,27(1):92-98.
  • 8Habibi J,Whaley-Connell A,Mahnaz A.et al.Rosuvastatin,a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats[J].Endocrinology,2007,148(5):2181-2188.
  • 9Luan ZX,Chase AJ,Andrew C,et al.Statins inhibit secretion of metalloproteinases-1,-2,-3,and -9 from vascular smooth muscle cells and macrophages[J].Arterioscler Thromb Vasc Biol,2003,23(5):769-775.
  • 10Tartakover-Matalon S,Cherepnin N,Kuchuk M,et al.Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor,MMP2 activity and HSP27 expression[J].Hum Reprod,2007,22(4):1161-1167.

共引文献42

同被引文献101

引证文献10

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部